Skip to Main Content

Paper Details

STING agonist promotes CAR T cell trafficking and persistence in breast cancer.
J Exp Med
85
2021
CAR, CAR T cell, CAR T cells, DMXAA, STING, T cell, Th/Tc17, Th/Tc17 CAR T, Th/Tc17 cells, anti-GR-1 mAb, anti-PD-1, breast cancer, cGAMP, immune-stimulatory and suppressive myeloid cells, locally advanced breast cancer, single, solid tumors, tumor
Author NameAffiliation
Benjamin G VincentUniversity of North Carolina at Chapel Hill
Benjamin G VincentLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Benjamin G VincentUniversity of North Carolina at Chapel Hill
Benjamin G VincentUniversity of North Carolina at Chapel Hill
Benjamin G VincentUniversity of North Carolina at Chapel Hill
Nicholas P RestifoCenter for Cancer Research, National Cancer Institute
Nicholas P RestifoCenter for Cancer Research, National Cancer Institute
Jonathan S SerodyUniversity of North Carolina at Chapel Hill
Jonathan S SerodyLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Jonathan S SerodyUniversity of North Carolina at Chapel Hill
Jonathan S SerodyUniversity of North Carolina at Chapel Hill
  • 1 - 11

Datasets

Release 1.2